Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1.

Dao T, Pankov D, Scott A, Korontsvit T, Zakhaleva V, Xu Y, Xiang J, Yan S, de Morais Guerreiro MD, Veomett N, Dubrovsky L, Curcio M, Doubrovina E, Ponomarev V, Liu C, O'Reilly RJ, Scheinberg DA.

Nat Biotechnol. 2015 Oct;33(10):1079-86. doi: 10.1038/nbt.3349. Epub 2015 Sep 21.

2.

Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein.

Veomett N, Dao T, Liu H, Xiang J, Pankov D, Dubrovsky L, Whitten JA, Park SM, Korontsvit T, Zakhaleva V, Casey E, Curcio M, Kharas MG, O'Reilly RJ, Liu C, Scheinberg DA.

Clin Cancer Res. 2014 Aug 1;20(15):4036-46. doi: 10.1158/1078-0432.CCR-13-2756. Epub 2014 May 21.

3.

Therapeutic antibodies to intracellular targets in cancer therapy.

Veomett N, Dao T, Scheinberg DA.

Expert Opin Biol Ther. 2013 Nov;13(11):1485-8. doi: 10.1517/14712598.2013.833602. Epub 2013 Aug 31.

PMID:
23991764
4.

A self-assembling short oligonucleotide duplex suitable for pretargeting.

Mallikaratchy P, Gardner J, Nordstrøm LU, Veomett NJ, McDevitt MR, Heaney ML, Scheinberg DA.

Nucleic Acid Ther. 2013 Aug;23(4):289-99. doi: 10.1089/nat.2013.0425. Epub 2013 Jul 13.

5.

Targeting the intracellular WT1 oncogene product with a therapeutic human antibody.

Dao T, Yan S, Veomett N, Pankov D, Zhou L, Korontsvit T, Scott A, Whitten J, Maslak P, Casey E, Tan T, Liu H, Zakhaleva V, Curcio M, Doubrovina E, O'Reilly RJ, Liu C, Scheinberg DA.

Sci Transl Med. 2013 Mar 13;5(176):176ra33. doi: 10.1126/scitranslmed.3005661.

6.

A high-throughput scintillation proximity-based assay for human DNA ligase IV.

Tseng HM, Shum D, Bhinder B, Escobar S, Veomett NJ, Tomkinson AE, Gin DY, Djaballah H, Scheinberg DA.

Assay Drug Dev Technol. 2012 Jun;10(3):235-49. doi: 10.1089/adt.2011.0404. Epub 2011 Dec 22.

Supplemental Content

Loading ...
Support Center